Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IMA stock hub

ImageneBio, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IMAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

59.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IMA

In the news

Latest news · IMA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-86.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-54

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IMA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

165

Groups with data

Currency

USD

Showing 165 of 165 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001835579
Company name	ImageneBio, Inc.
Country	United States
Country code	US
Cusip	45175G207
Employees	15
Employees Change	5%
Employees Change Percent	50
Enterprise value	$-55.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US45175G2075
Last refreshed	2026-05-10
Market cap	$59.2M
Market cap category	Micro-Cap
Price	$5.29
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	IMA
Website	https://www.inmagenebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-96.23%
FCF yield	-93.65%
P/B ratio	0.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-56.9M
Net Income Growth Years	0%
Profit Per Employee	$-3.8M
ROA	-45.61
ROCE	-41.93
ROE	-86.15
ROIC	-53.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	-77.14x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$136.7M
Cash	$117.2M
Current Assets	$122M
Current Liabilities	$6.6M
Debt	$2.4M
Debt Equity	$0.02
Equity	$123.3M
Liabilities	$13.4M
Long Term Assets	$14.7M
Long Term Liabilities	$6.7M
Net Cash	$114.8M
Net Cash By Market Cap	$194
Net Debt Equity	$-0.93
Tangible Book Value	$123.3M
Tangible Book Value Per Share	$10.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	18.39
Net Working Capital	$470,000
Quick ratio	17.67
Working Capital	$115.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	98.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	5.67
All Time High	18
All Time High Change	-70.61%
All Time High Date	2025-07-28
All Time Low	3.94
All Time Low Change	34.26%
All Time Low Date	2026-03-27
ATR	0.44
Beta1y	1.49
Ch YTD	-23.33
High	5.9
High52	18
High52 Date	2025-07-28
High52ch	-70.61%
Low	5.28
Low52	3.94
Low52 Date	2026-03-27
Low52ch	34.26%
Ma50ch	-6.73%
Premarket Change Percent	1.18
Premarket Price	$5.98
Premarket Volume	282
RSI	42.18
RSI Monthly	0
RSI Weekly	30.56
Sharpe ratio	-1.46x
Sortino ratio	-1.87
Total Return	98.35%
Tr YTD	-23.33
Tr1m	11.37%
Tr1w	-6.54%
Tr3m	-23.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	2
Analyst Price Target Top	$16
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.68
Operating Income	$-54.5M
Price target	$16
Price Target Change	$202
Price Target Change Top	$202

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,264,715%
Float Percent	56.01%
Net Borrowing	15,000,000
Shares Insiders	1.58%
Shares Institutions	21.36%
Shares Out	11,184,995
Shares Qo Q	8.82%
Shares Yo Y	-98.35%
Short Float	9.37%
Short Ratio	0.64
Short Shares	5.25

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-71.6M
Average Volume	1,026,990.85x
Bv Per Share	10.93
Ch1m	11.37
Ch1w	-6.54
Ch3m	-23.44
Ch6m	-36.19
Change	-10.49%
Change From Open	-6.87
Close	5.91
Days Gap	-3.89
Depreciation Amortization	496,750
Dollar Volume	398,130.7
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-54.5M
EBITDA	$-54M
EPS	$-7.46
F Score	2
FCF	$-55.4M
FCF EV Yield	99.62x
FCF Per Share	$-4.95
Financing CF	132,197,000
Fiscal Year End	December
Founded	2,019
Income Tax	$-340,000
Investing CF	-6,254,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	6.69
Ma150ch	-20.91%
Ma20	5.83
Ma20ch	-9.2%
Net CF	71,130,000
Next Earnings Date	2026-08-15
Open	5.68
Optionable	No
Position In Range	1.61
Post Close	5.29
Postmarket Change Percent	2.27
Postmarket Price	$5.41
Ppne	616,000
Pre Close	5.91
Price Date	2026-05-08
Ptbv Ratio	0.48
Relative Volume	0.07x
Share Based Comp	16,210,000
Tr6m	-36.19%
Us State	California
Volume	75,261

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IMA pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns IMA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.4%

Float: +56.0% of shares outstanding

Insider ownership

+1.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IMA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.2

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IMA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMA stock rating?

ImageneBio, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMA analysis?

The full report lives at /stocks/IMA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMA?

The latest report frames IMA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.